Keystone Financial Group »

Leap Therapeutics shares owned by Keystone Financial Group

Quarter-by-quarter ownership of Leap Therapeutics (CYPH) shares owned by Keystone Financial Group from 13F filings

Historical chart of Keystone Financial Group investment in Leap Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Leap Therapeutics held by Keystone Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Leap Therapeutics by Keystone Financial Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $14k 12k 1.16

More positions owned by Keystone Financial Group

Apple Equities (AAPL)
SPDR S&P Equities (SPY)
Palantir Technologies Equities (PLTR)
State Street Equities (SPYM)
Victoryshares Free Equities (VFLO)
Tesla Equities (TSLA)
Vanguard Total Equities (VTI)
Nvidia Corp Equities (NVDA)
State Street Equities (SPYG)
Ishares U S Equities (DYNF)
Microsoft Corp Equities (MSFT)
Berkshire Hathaway Equities (BRK.B)
Vanguard S&p Equities (VOO)
Amazon Equities (AMZN)
Meta Platforms Equities (META)

View all positions for Keystone Financial Group

Top funds holding Leap Therapeutics

Gilead Sciences
Vanguard Group
HighTower Advisors
Simplify Asset Management
Geode Capital Management
Jane Street
State Street Corporation
BlackRock
Hrt Financial
Texas Capital Bank Wealth Management Services
Two Sigma Advisers
Susquehanna International
Key Client Fiduciary Advisors
Citadel Advisors
Two Sigma Investments

View all funds holding Leap Therapeutics